Replies to post #297165 on NorthWest Biotherapeutics Inc (NWBO)

[Hopeforthefuture3]

Longfellow, I totally have that paper. If you will watch the presentation by Bosch on June 2 2019 about minute 18 or 20 (had exact time the other day) he clearly tells that he can't give a detailed update as there is a paper on updated results in the works. That is the paper I'm talking about not the one from 2018. If there was no paper in the works then I would have expected Bosch to give a real update with the charts and tables that had been shown over time previously.

Seems any update and or paper have dissapeared

The link to the Bosch presentation is in the ihub links - please go back and even just fast forward to the time I referenced and you can see for yourself

In that same talk Bosch speaks on the information arm on L. Another item of information that has dissapeared is any mention of the group of confirmed pseudoprogressors. Imo this should be a very interesting group as if their pseudoprogression was due to tcells (til) then imo this group should have excellent survival. I asked IR about this and was dismissed as being too small a group yet information arm is similar in size and they like to talk about that

[Hopeforthefuture3]

Longfellow, the paper I'm talking about is mentioned by Bosch at minute 18:59 from his June 2 2019 presentation.

It is in the ihub links. If you scroll to the "webcasts" it is the first link "ASCO 2019 - Clinical Trial Program Update: Presentation by Dr. Marnix Bosch - June 2 2019"

This is the promised paper not the 2018 paper